NASDAQ:AXON

Axon Enterprise Stock Forecast, Price & News

$157.95
+1.10 (+0.70 %)
(As of 06/21/2021 11:45 AM ET)
Add
Compare
Today's Range
$154.69
$158.85
50-Day Range
$123.43
$159.29
52-Week Range
$78.28
$212.37
Volume3,820 shs
Average Volume553,601 shs
Market Capitalization$10.22 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.48
30 days | 90 days | 365 days | Advanced Chart
Receive AXON News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.


Axon Enterprise logo

About Axon Enterprise

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy weapons (CEWs) under the TASER brand in the United States and internationally. It operates through two segments, TASER and Software and Sensors. The company offers TASER X26P, TASER X2, TASER 7, and TASER Pulse CEWs; and related cartridges. It also provides on-officer body cameras and Axon Fleet in-car video systems; and Axon Evidence digital evidence management software; Axon Records, a cloud-based records management system; Axon Signal enabled devices; and computer-aided dispatch software, as well as Axon docks, cartridges, and batteries. In addition, the company offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.44 out of 5 stars

Industrial Products Sector

148th out of 408 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

6th out of 12 stocks

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Axon Enterprise (NASDAQ:AXON) Frequently Asked Questions

Is Axon Enterprise a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last year. There are currently 1 hold rating, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Axon Enterprise stock.
View analyst ratings for Axon Enterprise
or view top-rated stocks.

What stocks does MarketBeat like better than Axon Enterprise?

Wall Street analysts have given Axon Enterprise a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Axon Enterprise wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Axon Enterprise's next earnings date?

Axon Enterprise is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Axon Enterprise
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) issued its quarterly earnings data on Wednesday, May, 5th. The biotechnology company reported $0.31 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.21 by $0.10. The biotechnology company had revenue of $195.02 million for the quarter, compared to analysts' expectations of $165.84 million. Axon Enterprise had a negative trailing twelve-month return on equity of 6.05% and a negative net margin of 7.37%. The company's revenue was up 32.5% on a year-over-year basis.
View Axon Enterprise's earnings history
.

How has Axon Enterprise's stock been impacted by Coronavirus (COVID-19)?

Axon Enterprise's stock was trading at $2.82 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXON stock has increased by 5,440.8% and is now trading at $156.25.
View which stocks have been most impacted by COVID-19
.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2021 earnings guidance on Thursday, May, 27th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $780 million-$820 million, compared to the consensus revenue estimate of $760.61 million.

What price target have analysts set for AXON?

6 Wall Street analysts have issued twelve-month price objectives for Axon Enterprise's stock. Their forecasts range from $150.00 to $200.00. On average, they anticipate Axon Enterprise's stock price to reach $176.80 in the next twelve months. This suggests a possible upside of 13.2% from the stock's current price.
View analysts' price targets for Axon Enterprise
or view top-rated stocks among Wall Street analysts.

Who are Axon Enterprise's key executives?

Axon Enterprise's management team includes the following people:
  • Mr. Patrick W. Smith, Co-Founder, CEO & Director (Age 50, Pay $27.97k)
  • Mr. Luke S. Larson, Pres (Age 40, Pay $677.99k)
  • Mr. Jawad A. Ahsan, Chief Financial Officer (Age 42, Pay $656.16k)
  • Mr. Joshua M. Isner, Chief Revenue Officer (Age 35, Pay $1.1M)
  • Mr. Jeffrey C. Kunins, Chief Product Officer & Exec. VP of Software (Age 46, Pay $600.74k)
  • Mr. Josh Goldman, Sr. VP of Operations
  • Mr. Jenner Holden, Chief Information Security Officer
  • Ms. Andrea Susan James, Sr. VP of Investor Relations & Corp. Strategy
  • Mr. Isaiah Fields, Corp. Sec. & Gen. Counsel
  • Sydney Siegmeth, VP of Global Communications

Who are some of Axon Enterprise's key competitors?

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), (CGC), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering (IPO) on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

How do I buy shares of Axon Enterprise?

Shares of AXON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $156.25.

How much money does Axon Enterprise make?

Axon Enterprise has a market capitalization of $10.11 billion and generates $681 million in revenue each year. The biotechnology company earns $-1,720,000.00 in net income (profit) each year or $0.11 on an earnings per share basis.

How many employees does Axon Enterprise have?

Axon Enterprise employs 2,548 workers across the globe.

What is Axon Enterprise's official website?

The official website for Axon Enterprise is www.axovant.com.

Where are Axon Enterprise's headquarters?

Axon Enterprise is headquartered at 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company can be reached via phone at (480) 991-0797 or via email at [email protected]


This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.